Find and compare companies providing services for:
Drug Product (CMO)
Filters
Production region
Production scale
Qualifications
CMO
Plants in:
Established in: 2008
Production scale:
large
small
medium
Employees: 4.000

With 14 production sites in Europe and the USA

7 Development Centers of Excellence covering all dosage forms

13 locations with Technology Services on site for seamless Tech Transfer and product Life-Cycle Management
All certificates
Replies quickly
CMO

Specialized in complex product development and manufacturing.

High-quality standards with a focus on customer-specific needs.

Agile and innovative approach to CDMO services.
All certificates
Replies quickly
Plants in:
Established in: 1886
Production scale:
medium
small
Employees: 275+

Raw materials, CMO and OTC products

Two GMP certified locations

Customisable (small-sized) packages
All certificates
Replies quickly
Plants in:
Established in: 2023
Production scale:
small
medium
large
Employees: 1000+

Expertise in Conventional, Complex, and Niche Chemistries

End-to-end Support from early development to Commercial Phases

Comprehensive Analytical Support Facilities
All certificates
Replies quickly
CMO
Plants in:
Established in: 1975
Production scale:
small
medium
large
Employees: 234

45+ years of experience in oral solid and nonsterile oral liquid

Specialization in pediatric, geriatric, and controlled-substance

Reliable and flexible full-service production partner
All certificates
Replies quickly
CMO
Plants in:
Established in: 1998
Production scale:
small
medium
large
Employees: 1000

Facilities with global regulatory compliance

Customized and Flexible Collaboration Models

End-to-end drug discovery
All certificates
Replies quickly
Plants in:
Established in: 2016
Production scale:
medium
small

Low Volume high value API Fill and Finish Service

In-line monitoring, SKAN Isolators, Highly Experienced Staff

Capacity Available, Ready for your API
All certificates
Replies quickly
CMO
Plants in:
Established in: 1972
Production scale:
medium
Employees: 1,000+

EU-GMP for APIs and CEP for certain APIs

Exporting to over 50 countries worldwide

Long-standing technological advantage in adamantane, quinuclidine and nitrofurane chemistry
All certificates
Replies quickly
CMO
Plants in:
Established in: 1991
Production scale:
small
medium
large
Employees: 3,500+

More than 12 GMP manufacturing facilities (EU, US, India)

Portfolio of more than 240 commercial APIs

We are experts in the cGMP production of highly potent compounds
All certificates
Replies quickly
Plants in:
Established in: 1982
Production scale:
small
Employees: 30+

Modern GMP facility

Team of academics and technical experts

Small to large batch sizes possible
All certificates
Replies quickly
Plants in:
Established in: 2014
Production scale:
small
medium
large
Employees: 1000+

24 years of production experience

6 workshops and 9 production lines which has 100t/month production capacity

4 USDMFS & 8 CEPS & 200+ Patents
All certificates
Replies quickly
CMO
Plants in:
Established in: 1934
Production scale:
large
small
medium
Employees: 1500

Full-Service CDMO with End-to-End Solutions

Reliable Global Distribution Operating in over 70 countries

Specialized in hormones, crystal-suspensions and complex injectables
All certificates
Replies quickly
Plants in:
Established in: 2016
Production scale:
small
medium
large
Employees: 200

PFAS-Free Peptides

Certified Quality & Sustainability with ISO 9000 certification and RSPO audited supplier & GMP

Specialized in APIs & Pharmaceutical Intermediates
All certificates
Replies quickly
CMO
Plants in:
Established in: 1964
Production scale:
small
medium
large
Employees: 135+

Market leader in Switzerland

Small and medium batch sizes

Pharmaceutical raw materials with a herbal or synthetic basis
All certificates
Replies quickly
CMO
Plants in:
Established in: 1955
Production scale:
small
medium
large
Employees: 500+

BFS expertise with FDA Approval for Sterile Manufacturing

USA and European Quality

Innovative solutions for ophthalmology and otorhinolaryngology
All certificates
Replies quickly
CMO
Plants in:
Established in: 2006
Production scale:
small
medium
large
Employees: 3500

Silver EcoVadis awardee committed to sustainability

Exceptional synthesis experience of HPAPIs

One-stop CDMO Solutions for APl and Key intermediates
All certificates
Replies quickly
Plants in:
Established in: 1987
Production scale:
medium
small
large
Employees: 50+

ISO 9001:2015 & SGS audited supplier

One-stop CDMO Solutions for APl and Key intermediates

Specialized in APIs & Pharmaceutical Intermediates for 38 years
All certificates
Replies quickly
CMO
Plants in:
Established in: 2006
Production scale:
small
medium
Employees: 20

Quality Assurance: Products are manufactured from the finest raw materials and undergo rigorous testing.

Tailored Customisation & Compliance: Providing end-to-end solutions to meet your business

Dependable Expertise and Supply: Backed by years of industry experience and a robust supply chain.
All certificates
Replies quickly
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+

6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO

R&D Centers with capabilities of ANDAs, DMFs and NDDS

462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
CMO
Plants in:
Established in: 2005
Production scale:
medium
small
Employees: 200+

Portfolio of over 2,000 APIs

Precise quality control

End-to-end global regulatory support
All certificates
Replies quickly
CMO

Leaders in dermatological product development and testing.

Innovative solutions for skin permeation and absorption studies.

Strong focus on client-centric, scientifically driven services.
All certificates
Replies slower than most
CMO

Specialized in sterile ophthalmic and injectable formulations.

Focus on flexibility and customization for client-specific needs.

Advanced manufacturing capabilities in a controlled environment.
All certificates
Replies slower than most
CMO

Specialized in liquid and semi-solid pharmaceuticals manufacturing.

Nordic excellence in quality and reliability.

Flexible production capabilities catering to a wide range of batch sizes.
All certificates
Replies slower than most

Strong heritage in pharmaceutical innovation and biotechnology.

Comprehensive range of services from early development to commercial supply.

Focus on quality, reliability, and sustainability in biopharmaceutical manufacturing.
All certificates
Replies slower than most
CMO

Specialized in sterile and non-sterile pharmaceutical manufacturing.

Focus on flexibility and customization for client-specific needs.

State-of-the-art technology ensuring quality and efficiency.
All certificates
Replies slower than most
CMO

Dedicated to high-quality ophthalmic and ENT product manufacturing.

Emphasis on natural and gentle formulations for sensitive applications.

Italian excellence in innovative product development and production.
All certificates
Replies slower than most
CMO

Excellence in aseptic filling and packaging solutions for biologics.

Customized solutions for pre-filled syringes, vials, and cartridges.

Strong track record in supporting global market launches.
All certificates
Replies slower than most

Expertise in cell therapy development and manufacturing.

Tailored solutions for autologous and allogeneic cell therapies.

Cutting-edge technology for scalable and efficient cell therapy production.
All certificates
Replies slower than most
CMO

Innovator in blow-fill-seal technology for sterile liquid dosages.

Expertise in unit dose packaging for ophthalmics and respiratory solutions.

State-of-the-art facilities ensuring precision and scalability.
All certificates
Replies slower than most
CMO

Leading in aerosol and transdermal drug delivery systems.

Expertise in both small molecule and biologic drug formulation.

Strong track record in bringing complex therapies to market.
All certificates
Replies slower than most
CMO
Plants in:
Established in: 1996
Production scale:
large
small
medium

Leading in biopharmaceutical development and biologic API production.

Comprehensive services from cell line development to commercial manufacturing.

Strong track record in delivering complex and high-quality biologics.
All certificates
Replies quickly
CMO

Leading global provider of plasma-derived medicines.

Strong focus on innovation in bioscience solutions.

Comprehensive services from plasma collection to finished product.
All certificates
Replies slower than most
CMO

Successfully inspected by TGA, PMDA, MHRA, ANVISA, Health Canada, MPA, IMB, & FDA

All facilities are in good standing with all regulatory authorities, including DEA, EPA, OSHA

Quality Management System and supporting analytical processes are almost 100% electronic
All certificates
Replies quickly
CMO
Plants in:
Established in: 1942
Production scale:
large

Over 100 unique marketed pharmaceutical products and 17 approved product applications since 2019

Manufacturing capacities : 3.5B Oral Solid doses and 2.0M liters of liquids per year

We specialize in contract manufacturing of Oral Solid Dose (OSD) and Liquids, including high potency substances and small molecules.
All certificates
Replies slower than most
Plants in:
Established in: 1962
Production scale:
large

500 millions of lozenges per year at the Aignan site

143 million packs per year at the Gien site

252 formulations per year at the Cahors site
All certificates
Replies slower than most
CMO

Expertise in ophthalmic drug delivery solutions.

Committed to high-quality standards and patient safety.

Innovative R&D for advanced ophthalmic formulations.
All certificates
Replies slower than most
CMO

Pioneering in advanced delivery technologies and development solutions.

Extensive global network ensuring supply chain resilience.

Tailored services across biologics, gene therapies, and pharmaceuticals.
All certificates
Replies slower than most
CMO

Advanced polymers technology for optimized drug delivery systems.

Global capabilities in complex formulations and specialty chemicals.

Emphasis on collaborative partnerships for innovative solutions.
All certificates
Replies slower than most
CMO
Plants in:
Established in: 2002
Production scale:
large

Specialized in biologics CDMO services with a focus on monoclonal antibodies.

Advanced facilities for clinical and commercial-scale manufacturing.

Strong commitment to quality and regulatory compliance.
All certificates
Replies slower than most
CMO

Comprehensive drug development services from molecule to market.

Expertise in nanomedicine and drug repurposing.

Tailored project management ensuring efficiency and transparency.
All certificates
Replies slower than most
Looking for Drug Product (CMO) Services?
Find a list of providers specializing in Drug Product (CMO). Navigate through our extensive selection to identify the supplier that aligns with your specific needs.
Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.
Drug Product (CMO)
What is Drug Product outsourcing (CMO)?
Drug Product is the finished dosage form patients use (tablets, capsules, injectables, sprays, creams, etc.). Drug Product outsourcing typically means working with a Contract Manufacturing Organization (CMO) to manufacture, validate, package, and release finished dosage forms under GMP for your target markets.
A pharmaceutical CMO focuses on manufacturing execution: tech transfer, GMP production, validation, packaging, and supply continuity. If you still need substantial formulation work or process development, you may need a broader contract development manufacturing organization scope. This directory is optimized for buyers who are comparing CMO services and contract manufacturing services by real-world fit.
- Choose a CMO when your process is defined and you need manufacturing capacity, validation, packaging, and predictable supply.
- Prioritize dosage form fit (sterile vs non-sterile, device needs, line compatibility, packaging components).
- Verify regulatory readiness for your markets: FDA/EMA experience, documentation, change control, and release workflow.
- Use this pharmaceutical CMO directory to shortlist and request quotes from the right providers faster.
Drug Product buyer guide (CMO)
Use this quick guide to evaluate CMO services and avoid common delays in tech transfer, validation, and packaging.
How to choose the right Contract Manufacturing Organization
- Dosage form fit: match the exact formats you need (sterile vs non-sterile, device needs, packaging lines).
- Tech transfer ownership: confirm who owns documents, training, and change control.
- Validation strategy: align to stage and markets (clinical vs commercial).
- Packaging reality: line compatibility and component lead times are frequent blockers.
- Regulatory compliant CMO: confirm inspections/certifications relevant to your target markets.
What to include in your first message (RFQ)
- Dosage form: tablets/capsules, liquids, semi-solids, sterile injectables, inhalation, etc.
- Fill-finish format: vials, prefilled syringes, ampoules, lyophilized powders, pens.
- Stage + markets: investigational vs commercial; FDA/EMA/others.
- Volumes: batch size and annual demand estimate.
- Constraints: cold chain, device/combination requirements, special packaging.
- Timeline: desired start date, first batch, launch window.
Common pitfalls in Drug Product outsourcing
- Capacity surprises: the facility can do it, but not in your timeframe.
- Packaging constraints: components and line compatibility often take longer than expected.
- Validation gaps: misaligned validation scope causes delays and rework.
- Scope confusion: if development is still needed, pure CMO execution may not be enough.
Drug Product CMO services FAQ
Practical answers buyers look for when hiring a CMO and comparing contract manufacturing companies.
What is a Contract Manufacturing Organization (CMO)?
A CMO is a contract partner focused on manufacturing execution under GMP. For drug products this often includes tech transfer, validation, routine manufacturing, packaging, and supply continuity.
What does “CMO services” usually include?
Typical CMO services include tech transfer, GMP manufacturing, validation support, packaging, QC testing where applicable, and batch release workflows aligned to target markets.
When should I choose a CMO instead of a CDMO?
Choose a CMO when the formulation and process are largely established and you need manufacturing capacity and reliable supply. Choose CDMO scope when you still need development work (formulation/process development/method development).
How do I shortlist pharmaceutical CMO providers fast?
Start with dosage-form fit (sterile vs non-sterile, device needs), then filter by certifications and target markets (FDA/EMA), capacity, and realistic timelines. This directory is built for that workflow.
What should I include in an initial inquiry to a CMO?
Include dosage form, stage, batch sizes and annual demand estimate, target markets, packaging format, cold chain needs, and key quality expectations. Clear inputs lead to faster, more accurate proposals.
What is fill-finish and why does it matter?
Fill-finish is the step where drug product is filled into final containers (vials, syringes, pens) and packaged. Facility design, sterility assurance, and packaging components often drive timelines and feasibility.
How do I evaluate a regulatory compliant CMO?
Confirm market experience (FDA/EMA), inspectable quality systems (deviations/CAPA, change control), documentation readiness, and whether the specific facility/suites are in-scope for your product type.
What affects lead times the most in drug product contract manufacturing?
Capacity windows, packaging component lead times, validation strategy, and analytical/QC readiness are common drivers. Sterile injectables and complex packaging formats typically require longer planning.
Do contract manufacturers handle packaging too?
Many do, but packaging capability is not universal. Validate line compatibility, serialization requirements, component sourcing responsibilities, and release workflows.
What are “custom CMO services” and when do I need them?
Custom CMO services usually mean tailored packaging, special handling (cold chain), device requirements, or non-standard batch strategies. Use them when your product needs go beyond a standard manufacturing run.
How do I compare contract manufacturing companies fairly?
Compare on dosage-form fit, proven experience, certifications and market history, QA maturity, realistic lead times, and packaging capabilities. Use filters first, then deep-dive with RFQs.
Is an NDA required before contacting a CMO?
Often not for a high-level brief. Most buyers share a concise scope first and sign an NDA when detailed transfer documents are needed.
Why use a pharmaceutical CMO directory instead of searching manually?
Manual search is slow and inconsistent. A directory approach lets you compare providers by the same criteria (dosage form, certifications, markets, scale), so you can shortlist faster and avoid contacting mismatched suppliers.
What is the difference between contract manufacturing services and CDMO services?
Contract manufacturing services usually focus on execution and supply. CDMO services typically include development work alongside manufacturing. For drug product, choose based on whether you need development or mainly manufacturing capacity.
Can I send one request to multiple CMOs?
Yes. If you’re unsure, use the open inquiry option: one message with your requirements routed to relevant CMOs, helping you compare responses without repeating the same work.
What are pharma contract fillers?
“Pharma contract fillers” usually refers to CMOs that perform fill-finish operations, especially for sterile injectables. Verify container formats, aseptic capabilities, and packaging lines for your product.








































